Back
Veracyte, Inc. 10K Form
Buy
58
VCYT
Veracyte, Inc.
Last Price:
$32.22
Seasonality Move:
8.54%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive VCYT News And Ratings
See the #1 stock for the next 7 days that we like better than VCYT
VCYT Financial Statistics
Sales & Book Value
| Annual Sales: | $517.1M |
|---|---|
| Cash Flow: | $48.8M |
| Price / Cash Flow: | 20.34 |
| Annual Sales: | $16.50 |
| Price / Book: | 1.96 |
Profitability
| EPS (TTM): | 0.82120 |
|---|---|
| Net Income (TTM): | $66.4M |
| Gross Margin: | $354.6M |
| Return on Equity: | 5.39% |
| Return on Assets: | 4.88% |
Veracyte, Inc. Earnings Forecast
Key Veracyte, Inc. Financial Ratios
-
The Gross Profit Margin over the past 15 years for VCYT is 68.57%.
-
The Selling, General & Administrative Expenses for VCYT have been equal to 40.79% of Gross Profit Margin.
-
The Research & Development expenses have been 13.37% of Revenue.
-
The Interest Expense is 0.00% of Operating Income.
-
The Net Earning history of VCYT is 12.83% of Total Revenues.
-
Per Share Earnings over the last 15 years have been positive in 9 years.
Veracyte, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | VCYT |
| CUSIP: | 92337F |
| Website: | veracyte.com |
Debt
| Debt-to-Equity Ratio: | 0.03 |
|---|---|
| Current Ratio: | 8.15 |
| Quick Ratio: | 7.63 |
Price-to-Earnings
| Trailing P/E Ratio: | 39.16 |
|---|---|
| Forward P/E Ratio: | 18.2 |
VCYT Technical Analysis vs Fundamental Analysis
Buy
58
Veracyte, Inc. (VCYT)
is a Buy
Is Veracyte, Inc. a Buy or a Sell?
-
Veracyte, Inc. stock is rated a BuyThe current Veracyte, Inc. [VCYT] share price is $32.25. The Score for VCYT is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.